Sustained Release Excipients Market Size, Share, Industry Trends and Forecast to 2033
This report provides an in-depth analysis of the Sustained Release Excipients market, showcasing current market trends, forecasts for 2023-2033, and key insights into market dynamics, segmentation, and leading players within the industry.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.20 Billion |
| CAGR (2023-2033) | 7.8% |
| 2033 Market Size | $11.27 Billion |
| Top Companies | Evonik Industries AG, Gattefossé, Ashland Global Holdings Inc., BASF SE, FMC Corporation |
| Last Modified Date | 15 Nov 2024 |
Sustained Release Excipients Market Report (2023 - 2033)
Sustained Release Excipients Market Overview
What is the Market Size & CAGR of Sustained Release Excipients market in 2033?
Sustained Release Excipients Industry Analysis
Sustained Release Excipients Market Segmentation and Scope
Request a custom research report for industry.
Sustained Release Excipients Market Analysis Report by Region
Europe Sustained Release Excipients Market Report:
The European market is projected to expand from $1.38 billion in 2023 to $2.99 billion by 2033. A strong focus on research and development, coupled with stringent regulatory frameworks, encourages innovation in sustained release technologies within the pharmaceutical industry.Asia Pacific Sustained Release Excipients Market Report:
The Asia Pacific market is experiencing rapid growth, projected to increase from $1.05 billion in 2023 to $2.27 billion by 2033, driven by expanding pharmaceutical and nutraceutical sectors, along with rising health awareness among consumers. The region's significant investment in healthcare infrastructure also fosters market growth.North America Sustained Release Excipients Market Report:
North America is one of the leading regions, with the market expected to grow from $1.88 billion in 2023 to $4.07 billion by 2033. The robust healthcare system, high investment in drug development, and the presence of key market players make it a prominent market for sustained release excipients.South America Sustained Release Excipients Market Report:
In South America, the market is set to grow from $0.45 billion in 2023 to $0.99 billion by 2033, benefitting from increasing collaborations between local pharmaceutical companies and global excipient manufacturers. The rise in chronic diseases and an aging population are also key factors propelling market expansion.Middle East & Africa Sustained Release Excipients Market Report:
The Middle East and Africa market is anticipated to grow from $0.44 billion in 2023 to $0.96 billion by 2033, as countries in the region enhance their healthcare capabilities and improve access to advanced therapeutic solutions, thus driving demand for sustained release excipients.Request a custom research report for industry.
Sustained Release Excipients Market Analysis By Product Type
Global Sustained-Release Excipients Market, By Product Type Market Analysis (2023 - 2033)
The by-product type segment highlights that polymers dominate the sustained release excipients market, projected to reach $7.34 billion by 2033 from $3.39 billion in 2023, holding a significant market share of 65.14%. Lipids will see growth from $1.06 billion in 2023 to $2.30 billion by 2033, maintaining a 20.36% share. Hydrogels are expected to grow from $0.75 billion to $1.63 billion, with a 14.5% share, showcasing their importance in various formulations.
Sustained Release Excipients Market Analysis By Application Area
Global Sustained-Release Excipients Market, By Application Area Market Analysis (2023 - 2033)
By application area, pharmaceuticals are leading the segment with a market size of $5.64 billion by 2033, up from $2.60 billion in 2023, maintaining a share of 50.05%. Nutraceuticals will experience growth from $1.30 billion to $2.82 billion, capturing 24.99% share. Biotechnology and cosmetics will also grow steadily, holding shares of 13.04% and 11.92%, respectively.
Sustained Release Excipients Market Analysis By Manufacturing Process
Global Sustained-Release Excipients Market, By Manufacturing Process Market Analysis (2023 - 2033)
The manufacturing process segment reveals that spheronization remains the leading process, projected to grow from $3.39 billion in 2023 to $7.34 billion by 2033 with a 65.14% market share. Extrusion and granulation processes are also poised for growth, with sizes of $1.06 billion (up to $2.30 billion) and $0.75 billion (up to $1.63 billion) in the same timeframe, holding shares of 20.36% and 14.5%, respectively.
Sustained Release Excipients Market Analysis By End User Industries
Global Sustained-Release Excipients Market, By End-User Industries Market Analysis (2023 - 2033)
In terms of end-user industries, pharmaceutical manufacturers account for a substantial portion of the market, anticipated to grow from $3.39 billion in 2023 to $7.34 billion by 2033 (65.14% share). Dietary supplement manufacturers will also see an increase from $1.06 billion to $2.30 billion (20.36% share), alongside notable growth in research institutes, which will rise from $0.75 billion to $1.63 billion (14.5% share).
Sustained Release Excipients Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Sustained Release Excipients Industry
Evonik Industries AG:
Evonik is a global leader in specialty chemicals, providing a broad range of excipients for the pharmaceutical industry, enhancing drug delivery systems and stability.Gattefossé:
A pioneering company in the field of excipients, Gattefossé specializes in lipids and offers advanced solutions for sustained release formulations.Ashland Global Holdings Inc.:
Ashland provides specialty chemical products and operates in various sectors, including pharmaceuticals, offering pharmaceutical excipients that enhance product performance.BASF SE:
BASF is a leading chemical company that produces a wide variety of excipients, boosting innovation in drug delivery and supporting the effective sustained release of medications.FMC Corporation:
FMC Corporation specializes in green solutions and provides a range of sustainable technologies, including excipients that support sustainable drug formulations.We're grateful to work with incredible clients.
